The Role of TREM1 in Ovarian Cancer
Author Information
Author(s): Tang Caihong, Ye Dong, He Qiong, He Qionghua, Zhou Wenkai, Lin Liya, Jiang Chao, Huang Da, Zhou Jianwei
Primary Institution: Second Affiliated Hospital, School of Medicine, Zhejiang University
Hypothesis
What is the prognostic value of TREM1 in ovarian cancer?
Conclusion
TREM1 could serve as a prognostic and immunological biomarker in ovarian cancer.
Supporting Evidence
- TREM1 expression is higher in ovarian cancer tissues compared to normal tissues.
- High TREM1 expression is linked to poor overall survival and disease-free survival in ovarian cancer patients.
- TREM1 was identified as an independent prognostic factor for ovarian cancer.
- Enrichment analysis showed TREM1 is involved in cancer- and immune-related pathways.
- TREM1 expression correlates positively with tumor-associated macrophages and regulatory T cells.
Takeaway
TREM1 is a protein that can help doctors understand how serious ovarian cancer is and how it affects the immune system.
Methodology
The study used bioinformatics analysis, survival analyses, and clinical sample validation to assess TREM1's role in ovarian cancer.
Potential Biases
Potential biases may arise from the reliance on existing databases and the lack of direct experimental validation.
Limitations
The study primarily relied on bioinformatics and public databases, and the specific expression level of TREM1 in ovarian cancer needs further investigation.
Participant Demographics
The study included 425 ovarian cancer patients from TCGA and 53 patients from GEO.
Statistical Information
P-Value
0.01743
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website